UNSPSC 85891449: Beam radiation of thymus using photons 1 - 10 mev

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of beam radiation of thymus using photons 1 - 10 mev. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code D7011ZZ

UNSPSC 85891449 Beam radiation of thymus using photons 1–10 mev is a Commodity code that shows a material mismatch between its nominal scope—highly specialized oncologic radiation therapy targeting the thymus gland—and the actual state and local procurement activity tagged to it. The recent opportunities block contains no solicitations for radiation therapy equipment, services, or consumables. Instead, the single recent record tags a County of Santa Clara Health System RFQ for temporary health professional staffing services across ancillary clinical categories including audiology, cardiology, diagnostic imaging, gastroenterology, respiratory care, and surgical services, work that falls outside the code's stated clinical domain and likely reflects a data-entry or classification error in the originating procurement record.

The mismatch between code and content renders this code unreliable for business development targeting in state and local markets. Thymus-targeted beam radiation is a rare, highly specialized procedure typically performed at academic medical centers and major cancer treatment facilities, and state and local procurement activity under this code does not support that scope. Firms specializing in oncologic radiation therapy, linear accelerator services, or thymus-cancer treatment protocols should monitor codes more directly aligned with imaging and radiation oncology services rather than rely on this commodity designation. The Santa Clara staffing RFQ due October 7, 2026, demonstrates that the code currently indexes general health system staffing work with no relevance to radiation oncology, signaling low utility for tracking genuine thymus-radiation opportunities at the state and local level.